Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Co-occurrence of multiple sclerosis and Parkinson disease.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
[The biological role of sulfatides].
Glial progenitor cell-based treatment of the childhood leukodystrophies.
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Astrocytes in multiple sclerosis.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.

Pages